Breaking News
Latest Blogs
Table of Contents
Volume 34, Issue 23 (March 16, 2026)
For full issue access, subscribers click here.
Articles
Pittcon Downsizes and Moves to San Antonio
Executive Briefing
The latest on HORIBA, Seer and more
Financial
Fourth Quarter Results: Agilent Technologies, Danaher, Sartorius, Thermo Fisher Scientific and Waters
Market Profile
Photoacoustic Imaging
Industry Watch
Government
Biopharma
Commodities
Region Watch
China
Asia
Latin America
News
MS, LC-MS, GC-MS
Sequencing
Informatics
Life Science Consumables
Gene-Based Analysis
Cell-Based Analysis
Protein-Based Analysis
Bottom Line
Comapanies’ latest financial results
New Report Details Higher Education Science R&D Spending
According to a report from the National Science Foundation published this month, in FY24 (ending September 30, 2024), overall R&D spending (science and engineering and non-science and engineering) by US higher education institutions grew 8.1% to $117,719 million. The federal government was the leading source of spending. But spending growth was the fastest for state […]
The Trials and Tribulations of the US Academic and Government End-Market in 2025: Presentation Highlights from the 44th JPMorgan Healthcare Conference
On February 7, 2025, the Trump administration announced a 15% cap on all indirect costs for new and existing NIH grants. However, on April 4, 2025, the US District Court in Massachusetts enacted a preliminary injunction blocking the limit. In response, the HHS appealed the injunction to the US Court of Appeals for the First […]
Single Use Leads Bioreactor Market Growth
A new report from Strategic Directions International (SDi), a business intelligence firm specializing in the analytical instrument market, finds that the compound annual growth rate (CAGR) between 2024 and 2029 of demand in the cell and gene therapy (C>) market for seven categories of analytical technologies will expand in the high single digits. The technologies […]
10x Genomics Debuts First Plate-Based Assay
10x Genomics has begun shipping its latest Flex assay for its Chromium instrument platform, responding to the needs of the single-cell sequencing market for easy to use, higher-throughput and scalable solutions. For example, the burgeoning field of cell atlases, or maps of an organism’s cells, requiring larger data sets and thus the faster generation of […]
Lab Tool Companies and Share Repurchases
Share repurchase programs have been a heavily discussed topic among investors and analysts, with some questioning their relationship to a company’s financial health. Among the leading reasons companies initiate share repurchase programs is to reduce the number of outstanding shares, thereby increasing the value of the remaining shares. Additionally, companies buy back shares to demonstrate […]